A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT01462292 · COMPLETED
Trial details
- NCT number
- NCT01462292
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-26
- Primary completion
- 2013-05-21
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.